Literature DB >> 2723484

[Establishment and characterization of human ovarian endometrioid carcinoma cell line].

T Fujii1.   

Abstract

A new cell line, designated as HOC-I, was established from a recurrent region of ovarian endometrioid carcinoma. HOC-I was subcultivated more than 55 times. 1) The monolayer culture cells showed a pavement like arrangement with polygonal cells and had a tendency to pile up. PAS positive substance could be seen in the cytoplasm. Desmosomes, microvilli and well developed cell organelles could be found by electron microscopy. 2) The population doubling time was about 75 hours. The chromosomal number showed pseudodiploidy of which the mode was 46. 3) By heterotransplantation to the nude athymic mouse, the tumor easily developed. 4) The effects of estradiol and progesterone on the cellular growth were assessed by the 3H-TdR uptake test. Estradiol increased 3H-TdR uptake of HOC-I but progesterone decreased it. These data suggested that HOC-I had sex-steroid hormone dependency. 5) Estrogen receptor was not detected in HOC-I by the ER-EIA method or the ER-ICA method. 6) The HOC-I cells produced CA125 and TPA in culture media.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2723484

Source DB:  PubMed          Journal:  Nihon Sanka Fujinka Gakkai Zasshi        ISSN: 0300-9165


  5 in total

1.  Production of various marker substances in human ovarian cancer cell lines of epithelial origin.

Authors:  S Sekiya; N Tanaka; H Takamizawa
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

2.  Urinary trypsin inhibitor (UTI) and fragments derived from UTI by limited proteolysis efficiently inhibit tumor cell invasion.

Authors:  H Kobayashi; H Shinohara; H Ohi; M Sugimura; T Terao; M Fujie
Journal:  Clin Exp Metastasis       Date:  1994-03       Impact factor: 5.150

3.  Establishment and characterization of a cell line (NOMH-1) originating from a human endometrioid adenocarcinoma of the ovary.

Authors:  Takashi Yamada; Takayoshi Kanda; Hiroshi Mori; Kaname Shimokawa; Mitsuo Kagawa; Yuro Shibayama
Journal:  J Ovarian Res       Date:  2013-02-04       Impact factor: 4.234

4.  Characterisation and clinical usefulness of CA130 antigen recognised by monoclonal antibodies, 130-22 and 145-9, in ovarian cancers.

Authors:  H Kobayashi; H Ohi; T Fujii; T Terao
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

5.  Saturation of tumour cell surface receptors for urokinase-type plasminogen activator by amino-terminal fragment and subsequent effect on reconstituted basement membranes invasion.

Authors:  H Kobayashi; H Ohi; H Shinohara; M Sugimura; T Fujii; T Terao; M Schmitt; L Goretzki; N Chucholowski; F Jänicke
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.